Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors This article is dedicated to Professor Jahyo Kang for his lifelong commitment to mentoring graduate students

Jung Eun Park, Chiman Song, Keehyun Choi, Taebo Sim, Bongjin Moon, Eun Joo Roh

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A series of 3,4-diarylpyrrolidin-2-one was designed, prepared and evaluated as triple reuptake inhibitors for antidepressant. Most compounds exhibited comparable in vitro efficacy as norepinephrine and dopamine transporter reuptake inhibitors. Especially, 2i showed better potency than GBR-12909 (IC 50 = 14 nM) which was used as reference compound for dopamine transporter. In addition, 2a and 2b showed inhibition (5.17 μM-85.6 nM) for three transporters.

Original languageEnglish
Pages (from-to)5515-5518
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume23
Issue number20
DOIs
Publication statusPublished - 2013 Oct 15

Fingerprint

Lactams
Dopamine Plasma Membrane Transport Proteins
Dopamine Uptake Inhibitors
Norepinephrine Plasma Membrane Transport Proteins
Students
Derivatives
Antidepressive Agents
Mentoring
vanoxerine
In Vitro Techniques

Keywords

  • Antidepressant
  • Depression
  • Dopamine
  • Lactam
  • Monoamine
  • Norepinephrine
  • Reuptake
  • Serotonin
  • Triple reuptake inhibitors

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors This article is dedicated to Professor Jahyo Kang for his lifelong commitment to mentoring graduate students. / Park, Jung Eun; Song, Chiman; Choi, Keehyun; Sim, Taebo; Moon, Bongjin; Roh, Eun Joo.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 23, No. 20, 15.10.2013, p. 5515-5518.

Research output: Contribution to journalArticle

@article{ea09ccb0a4cd4841817425760c284853,
title = "Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors This article is dedicated to Professor Jahyo Kang for his lifelong commitment to mentoring graduate students",
abstract = "A series of 3,4-diarylpyrrolidin-2-one was designed, prepared and evaluated as triple reuptake inhibitors for antidepressant. Most compounds exhibited comparable in vitro efficacy as norepinephrine and dopamine transporter reuptake inhibitors. Especially, 2i showed better potency than GBR-12909 (IC 50 = 14 nM) which was used as reference compound for dopamine transporter. In addition, 2a and 2b showed inhibition (5.17 μM-85.6 nM) for three transporters.",
keywords = "Antidepressant, Depression, Dopamine, Lactam, Monoamine, Norepinephrine, Reuptake, Serotonin, Triple reuptake inhibitors",
author = "Park, {Jung Eun} and Chiman Song and Keehyun Choi and Taebo Sim and Bongjin Moon and Roh, {Eun Joo}",
year = "2013",
month = "10",
day = "15",
doi = "10.1016/j.bmcl.2013.08.062",
language = "English",
volume = "23",
pages = "5515--5518",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "20",

}

TY - JOUR

T1 - Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors This article is dedicated to Professor Jahyo Kang for his lifelong commitment to mentoring graduate students

AU - Park, Jung Eun

AU - Song, Chiman

AU - Choi, Keehyun

AU - Sim, Taebo

AU - Moon, Bongjin

AU - Roh, Eun Joo

PY - 2013/10/15

Y1 - 2013/10/15

N2 - A series of 3,4-diarylpyrrolidin-2-one was designed, prepared and evaluated as triple reuptake inhibitors for antidepressant. Most compounds exhibited comparable in vitro efficacy as norepinephrine and dopamine transporter reuptake inhibitors. Especially, 2i showed better potency than GBR-12909 (IC 50 = 14 nM) which was used as reference compound for dopamine transporter. In addition, 2a and 2b showed inhibition (5.17 μM-85.6 nM) for three transporters.

AB - A series of 3,4-diarylpyrrolidin-2-one was designed, prepared and evaluated as triple reuptake inhibitors for antidepressant. Most compounds exhibited comparable in vitro efficacy as norepinephrine and dopamine transporter reuptake inhibitors. Especially, 2i showed better potency than GBR-12909 (IC 50 = 14 nM) which was used as reference compound for dopamine transporter. In addition, 2a and 2b showed inhibition (5.17 μM-85.6 nM) for three transporters.

KW - Antidepressant

KW - Depression

KW - Dopamine

KW - Lactam

KW - Monoamine

KW - Norepinephrine

KW - Reuptake

KW - Serotonin

KW - Triple reuptake inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84884282193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884282193&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2013.08.062

DO - 10.1016/j.bmcl.2013.08.062

M3 - Article

VL - 23

SP - 5515

EP - 5518

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 20

ER -